This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Imig, J. D. Articles by Inscho, E. W. Search for Related Content PubMed PubMed Citation Articles by Imig, J. D. Articles by Inscho, E. W. Related Collections Cell signalling/signal transduction Endothelium/vascular type/nitric oxide

(Hypertension. 2000;35:307.)
© 2000 American Heart Association, Inc.

Scientific Contributions

Cytochrome P450 and Cyclooxygenase Metabolites Contribute to the Endothelin-1 Afferent Arteriolar Vasoconstrictor and Calcium Responses

John D. Imig; Bao Thang Pham; Elizabeth A. LeBlanc; K. Malla Reddy; John R. Falck; Edward W. Inscho

From the Department of Physiology, Tulane University School of Medicine, New Orleans, La (J.D.I., B.T.P., E.A.L., E.W.I.), and the Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas (K.M.R., J.R.F.).

Correspondence to John D. Imig, PhD, Department of Physiology, SL39, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112. E-mail jdimig{at}mailhost.tcs.tulane.edu

Abstract—Arachidonic acid metabolites contribute to the endothelin-1 (ET-1)–induced decrease in renal blood flow, but the vascular sites of action are unknown. Experiments performed in vitro used the rat juxtamedullary nephron preparation combined with videomicroscopy. The response of afferent arterioles to ET-1 was determined before and after cytochrome P450 (CYP450) or cyclooxygenase (COX) inhibition. Afferent arteriolar diameter averaged 20±1 µm (n=17) at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.001 to 10 nmol/L ET-1 caused a graded decrease in diameter of the afferent arteriole. Vessel diameter decreased by 30±2% and 41±2% in response to 1 and 10 nmol/L ET-1, respectively. The afferent arteriolar response to ET-1 was significantly attenuated during administration of the CYP450 hydroxylase inhibitor N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS), such that afferent arteriolar diameter decreased by 19±3% and 22±3% in response to 1 and 10 nmol/L ET-1, respectively. COX inhibition also greatly attenuated the vasoconstriction elicited by ET-1, whereas the CYP450 epoxygenase inhibitor N-methylsulfonyl-6-(2-proparglyoxyphenyl) hexanamide enhanced the ET-1–mediated vascular response. Additional studies were performed using freshly isolated smooth muscle cells prepared from preglomerular microvessels. Renal microvascular smooth muscle cells were loaded with the calcium-sensitive dye fura 2 and studied by use of single-cell fluorescence microscopy. Basal renal microvascular smooth muscle cell [Ca²⁺]_i averaged 95±3 nmol/L (n=42). ET-1 (10 nmol/L) increased microvascular smooth muscle cell [Ca²⁺]_i to a peak value of 731±75 nmol/L before stabilizing at 136±8 nmol/L. Administration of DDMS or the COX inhibitor indomethacin significantly attenuated the renal microvascular smooth muscle cell calcium response to ET-1. These data demonstrate that CYP450 hydroxylase and COX arachidonic acid metabolites contribute importantly to the afferent arteriolar diameter and renal microvascular smooth muscle cell calcium responses elicited by ET-1.

Key Words: endothelin-1 • renal hemodynamics • cytochrome P450 • cyclooxygenase • cytosolic calcium • microcirculation

This article has been cited by other articles:

				B. Ponnuchamy and R. A. Khalil Cellular mediators of renal vascular dysfunction in hypertension Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2009; 296(4): R1001 - R1018. [Abstract] [Full Text] [PDF]

				J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF]

				A. Just, A. J. M. Olson, J. R. Falck, and W. J. Arendshorst NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1168 - R1177. [Abstract] [Full Text] [PDF]

				V. Randriamboavonjy, L. Kiss, J. R. Falck, R. Busse, and I. Fleming The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation Cardiovasc Res, February 1, 2005; 65(2): 487 - 494. [Abstract] [Full Text] [PDF]

				F. Zhang, H. Deng, R. Kemp, H. Singh, V. R. Gopal, J. R. Falck, M. Laniado-Schwartzman, and A. Nasjletti Decreased Levels of Cytochrome P450 2E1-Derived Eicosanoids Sensitize Renal Arteries to Constrictor Agonists in Spontaneously Hypertensive Rats Hypertension, January 1, 2005; 45(1): 103 - 108. [Abstract] [Full Text] [PDF]

				X. Zhao, J. R. Falck, V. R. Gopal, E. W. Inscho, and J. D. Imig P2X Receptor-Stimulated Calcium Responses in Preglomerular Vascular Smooth Muscle Cells Involves 20-Hydroxyeicosatetraenoic Acid J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1211 - 1217. [Abstract] [Full Text] [PDF]

				V. Randriamboavonjy, R. Busse, and I. Fleming 20-HETE-Induced Contraction of Small Coronary Arteries Depends on the Activation of Rho-Kinase Hypertension, March 1, 2003; 41(3): 801 - 806. [Abstract] [Full Text] [PDF]

				J.-I. Kaide, M.-H. Wang, J.-S. Wang, F. Zhang, V.R. Gopal, J. R. Falck, A. Nasjletti, and M. Laniado-Schwartzman Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries Am J Physiol Renal Physiol, January 1, 2003; 284(1): F51 - F56. [Abstract] [Full Text] [PDF]

				F. Xu, W. O. Straub, W. Pak, P. Su, K. G. Maier, M. Yu, R. J. Roman, P. R. Ortiz De Montellano, and D. L. Kroetz Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega -hydroxylase activity Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R710 - R720. [Abstract] [Full Text] [PDF]

				J. D. Imig, M. D. Breyer, and R. M. Breyer Contribution of prostaglandin EP2 receptors to renal microvascular reactivity in mice Am J Physiol Renal Physiol, September 1, 2002; 283(3): F415 - F422. [Abstract] [Full Text] [PDF]

				H. Hercule and A. Oyekan Renal Cytochrome P450 Oxygenases and Preglomerular Vascular Response to Arachidonic Acid and Endothelin-1 Following Ischemia/Reperfusion J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 717 - 724. [Abstract] [Full Text] [PDF]

				M. Alonso-Galicia, K. G. Maier, A. S. Greene, A. W. Cowley Jr., and R. J. Roman Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R60 - R68. [Abstract] [Full Text] [PDF]

				R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]

				X. Zhao, E. W. Inscho, M. Bondlela, J. R. Falck, and J. D. Imig The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction Am J Physiol Heart Circ Physiol, November 1, 2001; 281(5): H2089 - H2096. [Abstract] [Full Text] [PDF]

				J. D. Imig Eicosanoid regulation of the renal vasculature Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981. [Abstract] [Full Text] [PDF]

				B. A. Escalante, J. C. McGiff, and A. O. Oyekan Role of cytochrome P-450 arachidonate metabolites in endothelin signaling in rat proximal tubule Am J Physiol Renal Physiol, January 1, 2002; 282(1): F144 - F150. [Abstract] [Full Text] [PDF]